DiCE Molecules (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- January 08, 2021
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $80,000,000
Company Info
- Company Description
- DiCE Molecules is a biotechnology company utilizing its proprietary DNA-encoded library (DEL) technology, combined with unique structural insights, to generate small molecule antagonists against a range of protein-protein-interface (PPI) targets.
- Market
- Biotechnology and Pharmaceuticals
- Location
- South San Francisco, California, USA
- Coinvestors
- Alexandria Venture Investments, Altitude Life Sciences Ventures, Asymmetry Capital Management, Driehaus Capital Management, Eventide Asset Management, New Leaf Venture Partners, Northpond Ventures, Osage University Partners, RA Capital Management, Sands Capital, Sanofi Ventures, Soleus Capital